Jim Simons
ADPT icon

Jim Simons’s Adaptive Biotechnologies ADPT Stock Holding History

Jim Simons’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.33M Buy
+239,800
New +$3.82M 0.01% 1608
2025
Q4 		– Sell
-279,700
Closed -$4.18M – 3196
2025
Q3 		$4.18M Buy
279,700
+229,800
+461% +$2.8M 0.01% 1604
2025
Q2 		$581K Sell
49,900
-55,985
-53% -$509K ﹤0.01% 2760
2025
Q1 		$787K Sell
105,885
-123,900
-54% -$952K ﹤0.01% 2547
2024
Q4 		$1.38M Buy
229,785
+60,385
+36% +$333K ﹤0.01% 2301
2024
Q3 		$867K Buy
169,400
+17,600
+12% +$76.7K ﹤0.01% 2533
2024
Q2 		$550K Buy
151,800
+99,217
+189% +$315K ﹤0.01% 2656
2024
Q1 		$169K Buy
+52,583
New +$203K ﹤0.01% 3268
2023
Q4 		– Sell
-51,200
Closed -$279K – 3694
2023
Q3 		$279K Sell
51,200
-287,300
-85% -$1.9M ﹤0.01% 2960
2023
Q2 		$2.27M Sell
338,500
-55,500
-14% -$413K ﹤0.01% 1919
2023
Q1 		$3.48M Sell
394,000
-21,800
-5% -$192K ﹤0.01% 1691
2022
Q4 		$3.18M Sell
415,800
-42,000
-9% -$327K ﹤0.01% 1779
2022
Q3 		$3.26M Sell
457,800
-28,700
-6% -$270K ﹤0.01% 1709
2022
Q2 		$3.94M Buy
486,500
+30,900
+7% +$272K ﹤0.01% 1733
2022
Q1 		$6.32M Buy
+455,600
New +$7.16M 0.01% 1423
2021
Q2 		– Sell
-160,200
Closed -$6.45M – 3417
2021
Q1 		$6.45M Buy
+160,200
New +$8.67M 0.01% 1495

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jim Simons's ADPT Position: Q1 2026 in Review

Jim Simons opened a new position in Adaptive Biotechnologies (ADPT) in Q1 2026: 239,800 shares worth $3.33M. The stake represents 0.01% of the portfolio and ranks #1608 among its holdings. This is a return to the name: Jim Simons previously reported a position in ADPT as recently as Q3 2025.

Jim Simons first reported a position in ADPT in Q1 2021 and has held it in 16 quarters since. The position peaked at $6.45M in Q1 2021. 296 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Jim Simons held 239,800 shares of Adaptive Biotechnologies worth $3.33M as of Q1 2026.
  • Adaptive Biotechnologies was a new Jim Simons position in Q1 2026.
  • Adaptive Biotechnologies made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1608 holding.
  • Jim Simons first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 16 quarters since.
  • Jim Simons's Adaptive Biotechnologies position peaked at $6.45M in Q1 2021.
  • 296 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.